Review Article
Drosophila melanogaster Models of Friedreich’s Ataxia
Table 4
Compounds that showed beneficial effects in Drosophila models of FRDA.
| Compound | Mechanism of action | Improved phenotype |
| Idebenone | Antioxidant | Motor performance and lifespan in adults [42, 49] | Methylene blue | Electron carrier | Adult heart function [42] | Toluidine blue | Electron carrier | Adult heart function [42] | Deferiprone | Iron chelator | Motor performance and lifespan in adults [49] | Deferoxamine | Iron chelator | Pupa development [88] | LPS 01-03-L-F03 | Possible iron chelator | Pupa development [88] | LPS 02-25-L-E10 | Possible iron chelator | Pupa development [88] | LPS 02-13-L-E04 | Possible iron chelator | Pupa development [88] | LPS 01-04-L-G10 | n.d. | Pupa development [88] Adult heart function [88] | LPS 02-14-L-B11 | n.d. | Pupa development [88] | Rapamycin | TORC1 inhibitor | Motor performance and oxidative stress in adults [81] | Myriocin | Serine palmitoyltransferase inhibitor | Photoreceptor function [45] |
|
|
n.d.: not described.
|